Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage re
- This topic has 1 reply, 2 voices, and was last updated 3 years, 10 months ago by
.
Viewing 2 posts - 1 through 2 (of 2 total)
-
Posts
-
Thank you I have been closely monitoring this clinical trial. BAP1 is the gene mutation my husband has.
Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms (NCT03207347).
https://meetinglibrary.asco.org/record/188755/abstract
Viewing 2 posts - 1 through 2 (of 2 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.